Found: 20
Select item for more details and to access through your institution.
Inhibitor of apoptosis protein expression in glioblastomas and their in vitro and in vivo targeting by SMAC mimetic GDC-0152.
- Published in:
- Cell Death & Disease, 2016, v. 7, n. 8, p. e2325, doi. 10.1038/cddis.2016.214
- By:
- Publication type:
- Article
Coping with a newly diagnosed high-grade glioma: patient-caregiver dyad effects on quality of life.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 1, p. 155, doi. 10.1007/s11060-016-2161-6
- By:
- Publication type:
- Article
Neuro-oncological patients admitted in intensive-care unit: predictive factors and functional outcome.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 127, n. 1, p. 111, doi. 10.1007/s11060-015-2015-7
- By:
- Publication type:
- Article
Limited impact of prognostic factors in patients with recurrent glioblastoma multiforme treated with a bevacizumab-based regimen.
- Published in:
- Journal of Neuro-Oncology, 2013, v. 114, n. 2, p. 191, doi. 10.1007/s11060-013-1170-y
- By:
- Publication type:
- Article
Congrès Targeted Anticancer Therapies - TAT 2014.
- Published in:
- 2014
- By:
- Publication type:
- Report
P14.54 Primary central nervous system lymphoma of the spinal cord: a LOC network cohort study.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
P11.04 Autonomy duration as analyzed by KPS≥70 cumulative time in patients with biopsy-only glioblastoma (BO-GBM). A sub-analysis of the Timone cohort.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. ii29, doi. 10.1093/neuonc/noab180.100
- By:
- Publication type:
- Article
P04.08 Biopsy-only glioblastoma (BO-GBM) as a heterogeneous group of patients.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. ii20, doi. 10.1093/neuonc/noab180.065
- By:
- Publication type:
- Article
KS02.4.A Olaparib in Recurrent IDH-mutant High-Grade Glioma (OLAGLI).
- Published in:
- 2021
- By:
- Publication type:
- Abstract
P14.76 Characteristics of anaplastic oligodendrogliomas short-term survivors: a POLA network study.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii85, doi. 10.1093/neuonc/noz126.311
- By:
- Publication type:
- Article
P14.118 Carboxypeptidase G2 (CPG2) rescue after high dose methotrexate (hdMTX) chemotherapy for Primary CNS Lymphoma (PCNSL). A French LOC network study.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii96, doi. 10.1093/neuonc/noz126.353
- By:
- Publication type:
- Article
P13.09 Genomic analysis of paired IDHwt glioblastoma (GB) reveals recurrent alterations of MPDZ at relapse after radiotherapy and temozolomide (RTCT).
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii64, doi. 10.1093/neuonc/noz126.230
- By:
- Publication type:
- Article
OS8.5 How to assess meningioma therapy activity: The CEVOREM independent central review experience.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii16, doi. 10.1093/neuonc/noz126.055
- By:
- Publication type:
- Article
OS5.5 Characteristics of high-grade gliomas with H3 G34 mutation in adults.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii12, doi. 10.1093/neuonc/noz126.038
- By:
- Publication type:
- Article
OS1.7 Plasmatic differential scanning fluorimetry profiles discriminate glioma patients from healthy controls.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii7, doi. 10.1093/neuonc/noz126.020
- By:
- Publication type:
- Article
PL1.1 CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDHmutant gliomas.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii1, doi. 10.1093/neuonc/noz126.000
- By:
- Publication type:
- Article
P17.20 PATTERNS OF CARE AND OUTCOME FOR PATIENTS WITH RECURRENT GLIOBLASTOMA.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii91, doi. 10.1093/neuonc/nou174.350
- By:
- Publication type:
- Article
P08.07 LEPTOMENINGEAL GLIOMATOSIS: A SINGLE INSTITUTION RETROSPECTIVE STUDY OF 31 PATIENTS.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii51, doi. 10.1093/neuonc/nou174.195
- By:
- Publication type:
- Article
P04.08 PLASMA LEVELS AND TUMOR TISSUE RNA OF MMP2 AND MMP9 EXHIBIT SIMILAR DISTRIBUTION IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA (GB).
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii38, doi. 10.1093/neuonc/nou174.140
- By:
- Publication type:
- Article
P04.07 EXPRESSION PROFILE OF ANGIOGENIC FACTORS IN PAIRED INITIAL AND RECURRENT GLIOBLASTOMA.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii38, doi. 10.1093/neuonc/nou174.139
- By:
- Publication type:
- Article